Praxair, Inc.: Company Profile and SWOT Analysis

Document Sample
Praxair, Inc.: Company Profile and SWOT Analysis Powered By Docstoc
					Praxair, Inc.

_________________________________________________________________________________



Praxair, Inc.                                                             Financial Snapshot

                                                                          Operating Performance
Fast Facts
                                                                          The company reported revenues of US$10,116.00
Headquarters Address              39 Old Ridgebury Road, Danbury, 06810
                                                                          million during 2010, with a CAGR of 5.00% during
                                                                          2006–2010. Its revenue grew at an annual rate of
Telephone                         + 1 203 8372000
                                                                          12.95% over the previous fiscal year. In 2010, the
                                                                          company recorded an operating margin of 20.58%, as
Fax                               + 1 203 8372001                         against 17.59% in 2009.

Website                           www.praxair.com
                                                                          Revenue and Margins
Ticker Symbol, Stock Exchange     PX, New York Stock Exchange

Number of Employees               26,261

Fiscal Year End                   December

Revenue (in US$ million)          10,116.00




SWOT Analysis

Strengths                         Weaknesses                              Return on Equity

Diversified geographic presence   Increasing debt                         The company recorded a return on equity (ROE) of
                                                                          20.63% for 2010, as compared to its peers, Air
                                                                          Products and Chemicals, Inc. (Ticker: APD), Airgas,
Strong top-line performance       Lawsuits                                Inc. (Ticker: ARG) and Linde AG (Ticker: AMGN),
                                                                          which recorded ROEs of 18.55%, 10.93% and 9.26%
Wide business portfolio                                                   respectively. The company reported an operating
                                                                          margin of 20.58% in 2010.
Opportunities                     Threats
                                                                          Return on Equity
Construction of new plants        Environmental regulations

Contracts                         Foreign exchange risk

                                  Substitutes for renewable energy
Focus on Singapore operations
                                  sources




                                                                          Liquidity Position

                                                                          The company reported a current ratio of 1.13 in 2010,
                                                                          as compared to its peers, Air Products and
                                                                          Chemicals, Inc., Airgas, Inc. and Linde AG, which
                                                                          recorded current ratios of 1.35, 1.50 and 0.82
                                                                          respectively. As of December 2010, the company
                                                                          recorded cash and short-term investments of worth
                                                                          US$39.00 million, against US$32.00 million current
                                                                          debt. The company reported a debt to equity ratio of
                                                                          0.96 in 2010 as compared to its peers, Air Products
                                                                          and Chemicals, Inc., Airgas, Inc. and Linde AG, which
                                                                          recorded debt to equity ratios of 0.75, 0.87 and 0.62
                                                                          respectively.




___________________________________________________________________________________________

Praxair, Inc. - SWOT Profile                                                                                     Page 1
Praxair, Inc.

_________________________________________________________________________________


TABLE OF CONTENTS

1     Business Analysis ................................................................................................................................... 5
    1.1     Company Overview .................................................................................................................................................5
    1.2     Business Description ...............................................................................................................................................5
    1.3     Major Products and Services ...................................................................................................................................7
    1.4     Key Financial Performance Indicators .....................................................................................................................8
      1.4.1        Revenue and Operating Profit .........................................................................................................................8
      1.4.2        Asset, Liabilities and Capex ............................................................................................................................9
      1.4.3        Operational Efficiency ....................................................................................................................................10
      1.4.4        Solvency ........................................................................................................................................................11
      1.4.5        Valuation ........................................................................................................................................................12
    1.5     Competitive Benchmarking ....................................................................................................................................13
      1.5.1        Market Capitalization .....................................................................................................................................13
      1.5.2        Efficiency .......................................................................................................................................................14
      1.5.3        Capital Expenditure .......................................................................................................................................15
      1.5.4        Valuation ........................................................................................................................................................16
      1.5.5        Turnover – Inventory and Asset ....................................................................................................................17
      1.5.6        Liquidity ..........................................................................................................................................................18
2     Mergers & Acquisitions and Partnerships ........................................................................................... 19
    2.1     M&A and Partnerships Strategy ............................................................................................................................19
3     Recent Developments ........................................................................................................................... 23
4     SWOT Analysis ...................................................................................................................................... 25
    4.1     SWOT Analysis - Overview ...................................................................................................................................25
    4.2     Strengths ...............................................................................................................................................................25
    4.3     Weaknesses ..........................................................................................................................................................26
    4.4     Opportunities ........................................................................
				
DOCUMENT INFO
Description: This SWOT analysis and company profile is a crucial resource for industry executives and anyone looking to gain a better understanding of the company's business. ICD Research's "Praxair, Inc.: Company Profile and SWOT Analysis" report utilizes a wide range of primary and secondary sources, which are analyzed and presented in a consistent and easily accessible format. ICD Research strictly follows a standardized research methodology to ensure high levels of data quality and these characteristics guarantee a unique report.
BUY THIS DOCUMENT NOW PRICE: $99 100% MONEY BACK GUARANTEED
PARTNER ICD Research
With emphasis on Insight, Consultancy and Delivery, iCD Research is a full-service, online market research agency. iCD Research is able to take advantage of all of the efficiencies and benefits that the Internet brings to offer proven research methodologies with fast turnaround and accurate results. iCD Research specialises in qualitative research for large finance, media, retail and entertainment clients. Market leaders in online focus groups, iCD Research has unleashed the full scale of the Internet to run focus groups across the globe for its major institutional clients. Utilising its sister organisation, The iD Factor, iCD Research also delivers strong quantitative research, ranging from ongoing consumer confidence studies through to consumer surveys throughout Europe and Asia. With its roots firmly in research, iCD Research doesn’t limit itself to only utilising online methods as the philosophy at the company is to match the methodology to the respondent. Yet the scale and speed of online research give iCD Research a cutting edge that has lead to tremendous, triple-figure percentage growth over the past two years. iCD Research is headquartered in London, with operational offices in the US and Australia to ensure that it is offering an unparalleled 24 hour service to its clients.